Примери за използване на Ml of solvent in на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Polyvinylchloride bag containing 800 ml of solvent in individual over-pouch.
Ml of solvent in a vial(type I glass), with a stopper(rubber) a disc(plastic) and a cap(aluminium).
Powder(1 dose) in vial+ 0.5 mL of solvent in pre-filled syringe.
Ml of solvent in a vial(type I glass), with a stopper(rubber) a disc(plastic) and a cap(aluminium).
Polyvinylchloride bag containing 800 ml of solvent in individual over-pouch.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING Dengvaxia- Powder(5 doses)in vial+ 2.5 mL of solvent in vial.
Ml of solvent in a pre-filled syringe(Type I glass) closed with a tip cap(FluroTec coated butyl rubber).
PHARMACEUTICAL FORM AND CONTENTS Powder(5 doses) in vial+ 2.5 mL of solvent in vial Pack size of 5.
Powder in a vial(type I glass) with a stopper(butyl rubber),0.5 ml of solvent in a pre-filled syringe(type I glass) with a plunger stopper(butyl rubber) with or without separate needles in the following pack sizes.
Synagis is presented as a powder and solvent for solution for injection(100 mg of powder in vial)+ 1 ml of solvent in ampoule- Pack size of 1.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING Powder(1 dose) in vial+ 0.5 mL of solvent in pre-filled syringe with 2 separate needles.
IU, 500 IU, 1000 IU, 2000 IU or3000 IU lyophilised powder in top chamber and 4 mL of solvent in bottom chamber of the pre-filled syringe(type 1 glass) with butyl rubber plungers and closure, one plunger rod for assembly, a polypropylene vented sterile cap, a sterile infusion set, alcohol swabs, a plaster and a gauze pad.
SOMAVERT is presented as a powder and a solvent for injection(either 10 mg, 15 mg, 20 mg, 25 mg or30 mg pegvisomant in a vial and 1 ml of solvent in a pre-filled syringe).
Lyophilisate(50,000 IU) for solution for injection in a vial(type I glass) with a stopper(teflonised rubber)and 10 ml of solvent in an ampoule(type I glass), with one reconstitution and withdrawal device with one needle(21G2), and one disposable syringe(polypropylene and polyethylene)(10 ml). .
What SOMAVERT looks like and contents of the pack SOMAVERT is presented as a powder and a solvent for injection(either 10 mg, 15 mg, 20 mg, 25 mg or30 mg pegvisomant in a vial and 1 ml of solvent in a pre-filled syringe).
Each pack of VEYVONDI 650 IU contains:- powder in a glass vial with a rubber stopper- 5 mL of solvent in a glass vial with a rubber stopper- one reconstitution device(Mix2Vial).
IU powder in a 10 ml vial(type 1 glass) with a stopper(butyl) and a flip-off seal(aluminum)and 4 ml of solvent in a pre-filled syringe(type 1 glass) with a plunger stopper(butyl), a tip-cap(butyl) and a sterile vial adapter reconstitution device, a sterile infusion set, alcohol swabs, a plaster and a gauze pad.
VEYVONDI 650 IU powder and solvent for solution for injection Each pack contains:- powder in a vial(type I glass),with a butyl rubber stopper- 5 mL of solvent in a vial(type I glass), with a rubber stopper(chlorobutyl)- one reconstitution device(Mix2Vial).
IU of powder in a 10 ml vial(type 1 glass) with a stopper(chlorobutyl) and a flip-off seal(aluminium)and 5 ml of solvent in a prefilled syringe(type 1 glass) with a plunger stopper(bromobutyl), a tip-cap(bromobutyl) and a sterile vial adapter reconstitution device, a sterile infusion set, two alcohol swabs, a plaster, and a gauze pad.
Mg of white to almost white powder in a glass vial closed witha rubber stopper and a cap- 1.5 ml of solvent in a pre-filled syringe closed with a tip cap, for reconstitution as a clear solution.
Powder(5 doses) in vial(Type-I glass), with a stopper(halobutyl) and a flip-off cap(aluminium,polypropylene)+ 2.5 mL of solvent in vial(Type-I glass), with a stopper(halobutyl) and a flip-off cap(aluminium, polypropylene).
Each pack of VEYVONDI 1300 IU contains:- powder in a vial(type I glass),with a butyl rubber stopper- 10 mL of solvent in a vial(type I glass), with a rubber stopper(bromobutyl)- one reconstitution device(Mix2Vial).
Powder in a vial(type I glass) with a stopper(fluor-resin laminated butyl rubber), a strip(aluminium) anda cap(green polypropylene flip-off), and 1 ml of solvent in a cartridge(type I glass) with a stopper(fluor-resin laminated chlorobutyl elastomer), a strip(lacquered aluminium) and a cap(white polypropylene flip-off).
Augmentin 500 mg/50 mg should be dissolved in 10 ml of solvent.
Up to three vials of product may be dissolved in 1 ml of solvent.
ML extractable volume of solvent in a 2 mL cyclic olefin polymer vial with a chlorobutyl rubber stopper sealed in place with an aluminium flip-off seal.
Sterile lyophilised sphere in 1 ml ampoule(type I glass) and 1 ml of solvent(saline 0.45%) in 1 ml ampoule(type I glass).
To avoid injection of large volumes 3 to 4 cakes of Puregon may be dissolved in 1 ml of solvent.
Mg/ kg(up to a maximum of 25 mg per dose)after reconstitution of 25 mg Enbrel in 1 ml of solvent, given twice weekly as a subcutaneous injection with an interval of 3-4 days between doses.